Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma

被引:118
|
作者
Rosty, C
Sheffer, M
Tsafrir, D
Stransky, N
Tsafrir, I
Peter, M
de Crémoux, P
de La Rochefordière, A
Salmon, R
Dorval, T
Thiery, JP
Couturier, J
Radvanyi, F
Domany, E
Sastre-Garau, X
机构
[1] Inst Curie, Dept Biol Tumeurs, F-75248 Paris, France
[2] Inst Curie, CNRS, Oncol Mol UMR 144, F-75248 Paris, France
[3] Inst Curie, Dept Radiotherapy, F-75248 Paris, France
[4] Inst Curie, Dept Chirurg, F-75248 Paris, France
[5] Inst Curie, Dept Med Oncol, F-75248 Paris, France
[6] Inst Curie, Dept Tranfert, F-75248 Paris, France
[7] Weizmann Inst Sci, Dept Phys Complex Syst, Rehovot, Israel
关键词
cervical cancer; gene expression; HPV; prognosis; bioinformatics;
D O I
10.1038/sj.onc.1208854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Specific HPV DNA sequences are associated with more than 90% of invasive carcinomas of the uterine cervix. Viral E6 and E7 oncogenes are key mediators in cell transformation by disrupting TP53 and RB pathways. To investigate molecular mechanisms involved in the progression of invasive cervical carcinoma, we performed a gene expression study on cases selected according to viral and clinical parameters. Using Coupled Two-Way Clustering and Sorting Points Into Neighbourhoods methods, we identified a 'cervical cancer proliferation cluster' composed of 163 highly correlated transcripts. Most of these transcripts corresponded to E2F pathway genes controlling cell division or proliferation, whereas none was known as TP53 primary target. The average expression level of the genes of this cluster was higher in tumours with an early relapse than in tumours with a favourable course (P = 0.026). Moreover, we found that E6/E7 mRNA expression level was positively correlated with the expression level of the cluster genes and with viral DNA load. These findings suggest that HPV E6/E7 expression level plays a key role in the progression of invasive carcinoma of the uterine cervix via the deregulation of cellular genes controlling tumour cell proliferation. HPV expression level may thus provide a biological marker useful for prognosis assessment and specific therapy of the disease.
引用
收藏
页码:7094 / 7104
页数:11
相关论文
共 50 条
  • [31] Polymorphism of Interleukin-6 Is Not Associated with the Presence or Absence of High HPV E6/E7
    Cinti Porto, Claudia Regina
    Ferreira De Oliveira Kleine, Joao Paulo
    Longatto Filho, Adhemar
    Cotrim Guerreiro Da Silva, Ismael Dale
    ANTICANCER RESEARCH, 2014, 34 (07) : 3501 - 3504
  • [32] The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
    Zhang, Shao-Kai
    Guo, Zhen
    Wang, Peng
    Kang, Le-Ni
    Jia, Man-Man
    Wu, Ze-Ni
    Chen, Qiong
    Cao, Xiao-Qin
    Zhao, Dong-Mei
    Guo, Pei-Pei
    Sun, Xi-Bin
    Zhang, Jian-Gong
    Qiao, You-Lin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [33] E6/E7 mRNA Expression of High-risk HPV Types in 849 Greek Women
    Argyri, Elena
    Tsimplaki, Elpida
    Daskalopoulou, Dimitra
    Stravopodis, Dimitrios J.
    Kouikoglou, Ourania
    Terzakis, Emmanouil
    Panotopoulou, Efstathia
    ANTICANCER RESEARCH, 2013, 33 (09) : 4007 - 4011
  • [34] Viral E6/E7 oncogene and cellular hexokinase 2 expression in HPV-positive cancer cell lines
    Hoppe-Seyler, Karin
    Honegger, Anja
    Bossler, Felicitas
    Sponagel, Jasmin
    Bulkescher, Julia
    Lohrey, Claudia
    Hoppe-Seyler, Felix
    ONCOTARGET, 2017, 8 (63) : 106342 - 106351
  • [35] Novel action modality of the diterpenoid anisomelic acid causes depletion of E6 and E7 viral oncoproteins in HPV-transformed cervical carcinoma cells
    Paul, Preethy
    Rajendran, Senthil Kumar
    Peuhu, Emilia
    Alshatwi, Ali A.
    Akbarsha, Mohammad A.
    Hietanen, Sakari
    Eriksson, John E.
    BIOCHEMICAL PHARMACOLOGY, 2014, 89 (02) : 171 - 184
  • [36] Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes
    Miguel Aco-Tlachi
    Ricardo Carreño-López
    Patricia L. Martínez-Morales
    Paola Maycotte
    Adriana Aguilar-Lemarroy
    Luis Felipe Jave-Suárez
    Gerardo Santos-López
    Julio Reyes-Leyva
    Verónica Vallejo-Ruiz
    Infectious Agents and Cancer, 13
  • [37] Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes
    Aco-Tlachi, Miguel
    Carreno-Lopez, Ricardo
    Martinez-Morales, Patricia L.
    Maycotte, Paola
    Aguilar-Lemarroy, Adriana
    Felipe Jave-Suarez, Luis
    Santos-Lopez, Gerardo
    Reyes-Leyva, Julio
    Vallejo-Ruiz, Veronica
    INFECTIOUS AGENTS AND CANCER, 2018, 13
  • [38] Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer
    Jonson, Amy L.
    Rogers, Lisa M.
    Ramakrishnan, Sundaram
    Downs, Levi S., Jr.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 356 - 364
  • [39] Upregulation of PIR gene expression induced by human papillomavirus E6 and E7 in epithelial oral and cervical cells
    Carrillo, Diego
    Munoz, Juan P.
    Huerta, Hernan
    Leal, Gabriel
    Corvalan, Alejandro
    Leon, Oscar
    Calaf, Gloria M.
    Urzua, Ulises
    Boccardo, Enrique
    Tapia, Julio C.
    Aguayo, Francisco
    OPEN BIOLOGY, 2017, 7 (11):
  • [40] Efficacy of HPV E6/E7 mRNA assay, HPV DNA test and cytology in detection of high grade cervical lesions and invasive cancer at a tertiary care center in India
    Pankaj, Sangeeta
    Rani, Jyotsna
    Kumari, Pratibha
    Abhilashi, Kavya
    Choudhary, Vijayanand
    Kumari, Satya
    Shahi, Shivendra Kumar
    Xess, Anima
    Singh, Rajesh Kumar
    Kumar, Shishir
    Kumar, Abhay
    Biswas, Nihar Ranjan
    Jee, Babban
    MALAWI MEDICAL JOURNAL, 2024, 36 (02) : 120 - 127